Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neoplasms and NPC1L1[original query] |
---|
Using genetics to explore whether the cholesterol-lowering drug ezetimibe may cause an increased risk of cancer. International journal of epidemiology 2017 11 46 (6): 1777-1785. Kobberø Lauridsen Bo, Stender Stefan, Frikke-Schmidt Ruth, Nordestgaard Børge G, Tybjærg-Hansen An |
Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer. JAMA 2020 Feb 323 (7): 646-655. Yarmolinsky James, Bull Caroline J, Vincent Emma E, Robinson Jamie, Walther Axel, Smith George Davey, Lewis Sarah J, Relton Caroline L, Martin Richard |
A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer. Frontiers in genetics 2022 9 13 953997. Xin Dao, Man Yuxin, Yang Yalan, Wang Fe |
Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer. Breast cancer research : BCR 2022 Feb 24 (1): 12. Sun Lulu, Ding Huan, Jia Yiming, Shi Mengyao, Guo Daoxia, Yang Pinni, Wang Yu, Liu Fanghua, Zhang Yonghong, Zhu Zhengb |
Lipid-lowering medications and risk of malignant melanoma: a Mendelian randomization study. Frontiers in oncology 2024 7 14 1408972. BoWen Yang, HanYu Wang, WenYuan Song, JiuHuan Feng, ShuFang H |
Integrated singlecell and bulk RNA-seq analysis identifies a prognostic signature related to inflammation in colorectal cancer. Scientific reports 2025 1 15 (1): 874. Wen Yin, Yanting Ao, Qian Jia, Chao Zhang, Liping Yuan, Sha Liu, Wanmeng Xiao, Gang Luo, Xiaomin Shi, Chen Xin, Maolin Chen, Muhan Lü, Zehui |
- Page last reviewed:Feb 1, 2024
- Content source: